Quarterly report pursuant to Section 13 or 15(d)

Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details)

v3.21.1
Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Net income (loss) available to stockholders $ 1,766,707 $ (1,202,387)
Weighted average shares outstanding - Basic 24,850,261 24,850,250
Effect of dilutive securities:    
Weighted average shares outstanding - Diluted 25,122,271 24,850,250
Net income (loss) per share - basic (in USD per share) $ 0.07 $ (0.05)
Net income (loss) per share - diluted (in usd per share) $ 0.07 $ (0.05)
Stock Options    
Effect of dilutive securities:    
Stock options 272,010 0
Anti-dilutive shares underlying stock options outstanding 0 20,158